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The ‘three Ps’ of cancer survivorship care
Patricia A Ganz
What is the definition of ‘cancer survivor’ and
what is ‘survivorship care’?
With the growing numbers of individuals surviving long
term and disease free after a cancer diagnosis, a group
of individuals in the US came together in 1986 to estab-
lish the National Coalition for Cancer Survivorship
(NCCS; http://www.canceradvocacy.org), and defined
cancer survivors as individuals with cancer from the
time of diagnosis and for the balance of life, and
included in its definition family, friends and caregivers.
This broad and all-inclusive definition reminds us that
potentially anyone with a diagnosis of cancer can be a
long-term survivor and that we must design therapies at
the outset to maximize cure as well as minimize long-
term side effects and other more serious effects of can-
cer treatments. In practical terms, however, we tend to
focus on the post-treatment phase of the cancer experi-
ence, and that is where survivorship care really gets
started (Figure 1).
Why is survivorship care something that needs
dealing with?
The reason for the focus on survivorship care is that it
has been largely neglected. The medical care system pri-
marily focuses on curing the cancer and not on how to
manage the after effects. Patients are often left wonder-
ing about how often they need to be seen after treat-
ment ends and what follow-up tests need to be
performed. In addition, they are often troubled by per-
sistent symptoms and side effects of treatment that the
medical care system seldom attends to, and these pro-
blems may cause ongoing suffering and burden. Finally,
cancer survivors often neglect other aspects of their
health and may remain at risk for second cancers and
other serious chronic diseases (for example, heart dis-
ease, diabetes).
What are the ‘three Ps’?
As I began lecturing about survivorship care I wanted to
come up with something catchy to help people remem-
ber the important components of post-treatment survi-
vorship care. Conceptually, the care delivery falls into
three major domains: Palliation of ongoing symptoms;
Prevention of late effects of cancer treatment or second
cancers; and Health Promotion to maximize future
wellness. For example, the cancer may be gone, but
patients still can suffer from pain, fatigue or depression,
for which palliative care approaches become central.
Prevention of the late effects means monitoring and pre-
venting common late effects such as osteoporosis,
screening for second cancers (for example, skin exams,
breast cancer after chest radiation). Health promotion is
often overlooked because everyone is concentrating on
monitoring for cancer recurrence, when in fact many
adults are at risk for and will die from cardiovascular
disease, stroke or diabetes complications. Making sure
that all three Ps are addressed is an important aspect of
survivorship care.
What led to the development of these concepts?
I was a member of the Institute of Medicine (IOM)
committee that prepared a report on the challenges
associated with addressing the needs of post-treatment
cancer survivors (see Hewitt et al, 2006). This report
documented the growing number of cancer survivors
living after treatment ends and how they were ‘lost in
transition’ with little guidance or coordination in their
health care, and their unmet health care needs. The
report clearly states that there is a need to acknowledge
this phase of the cancer care trajectory, to do more
research to better understand how care should be pro-
vided, and to focus on improvement in the coordination
and quality of care through use of a treatment summary
and survivorship care plan.
What is the IOM?
The IOM is part of the US National Academy of
Sciences and is responsible for providing independent
unbiased advice on issues related to biomedical science,
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to the nation to improve health. It works outside the
framework of the US federal government to provide
independent guidance and analysis and relies on a
volunteer workforce of scientists and other experts,
operating under a rigorous, formal peer-review system
(see http://www.IOM.edu).
How well are these strategies being taken up in
the US?
In the 5 years that have elapsed since the IOM report
on adult cancer survivors, there has been increasing
awareness of the growing number of cancer survivors
in the US (now numbering about 12 million, or 4% of
t h ep o p u l a t i o n ) ,a sw e l la si n c r e a s i n ge f f o r t sa tm a j o r
cancer centers to develop programs that will improve
the post-treatment management of cancer patients.
However, widespread adoption of some of the key stra-
tegies and recommendations has been limited, with the
exception of many of the US National Cancer Institute
comprehensive cancer centers. This is mostly because
about 80% of cancer care in the US occurs in commu-
nity settings and not in major cancer centers. Small
groups of oncology practitioners are the norm, and the
surgeons and radiation oncologists often do not prac-
tice in the same setting with the medical oncologists.
Thus, the acute treatment and post-treatment care is
often fragmented, and usually does not include the
general practitioner. This makes it difficult to coordi-
nate post-treatment care and to ensure that the three
Ps are delivered when patients are in follow-up.
How about other parts of the world?
I think that the needs of cancer survivors are just begin-
ning to get attention in other parts of the world. The
U K ,A u s t r a l i a ,C a n a d aa n dp a r t so ft h eE Un o wh a v e
some of these same issues on their radar and are devel-
oping relevant models of care.
Figure 1 Cancer care trajectory and survivorship care. Figure adapted from the Institute of Medicine. Reprinted with permission from From
Cancer Patient to Cancer Survivor: Lost in Transition, 2005, by the National Academy of Sciences, Courtesy of the National Academies Press,
Washington, DC, USA.
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For childhood cancer survivors, the situation is a bit
more organized. They are fewer in number and are
almost all treated at specialized cancer centers across
the world. These centers often follow-up children who
were treated many years ago long into adulthood (for
example, for 30-40 years). These children often experi-
ence very serious side effects from treatment (for exam-
ple, short stature, endocrine deficiencies, second
cancers, premature cardiac disease) and as a result they
are more closely monitored. In the US, guidelines have
been developed for their care (see http://www.survivor-
shipguidelines.org/) by the Children’sO n c o l o g yG r o u p
(COG), and many follow-up clinics exist that are using
these guidelines which focus on the three Ps.
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